Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biofrontera Inc (BFRI)

Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,311
  • Shares Outstanding, K 5,089
  • Annual Sales, $ 34,070 K
  • Annual Income, $ -20,130 K
  • 60-Month Beta 0.44
  • Price/Sales 0.16
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BFRI with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.19
  • Number of Estimates 1
  • High Estimate -1.19
  • Low Estimate -1.19
  • Prior Year -6.14
  • Growth Rate Est. (year over year) +80.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8225 +50.76%
on 07/03/24
1.2550 -1.20%
on 07/26/24
+0.3300 (+36.26%)
since 06/26/24
3-Month
0.8225 +50.76%
on 07/03/24
2.1300 -41.78%
on 05/02/24
-0.3500 (-22.01%)
since 04/26/24
52-Week
0.6100 +103.28%
on 02/08/24
12.5600 -90.13%
on 07/27/23
-10.9700 (-89.84%)
since 07/26/23

Most Recent Stories

More News
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through...

PIXY : 1.6100 (+3.21%)
EW : 62.37 (+4.47%)
BFRI : 1.2400 (+12.73%)
LITE : 51.83 (+1.97%)
CUTR : 1.5200 (+8.57%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

/PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years....

PIXY : 1.6100 (+3.21%)
EW : 62.37 (+4.47%)
BFRI : 1.2400 (+12.73%)
LITE : 51.83 (+1.97%)
CUTR : 1.5200 (+8.57%)
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 1.2400 (+12.73%)
BFRIW : 0.0359 (-10.25%)
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0359 (-10.25%)
BFRI : 1.2400 (+12.73%)
Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence

Named Among the 10 Fastest-Growing Life Sciences Companies to Watch in 2022 by CIOCoverage Magazine New Ameluz® Marketing Campaign Receives Gold 2022...

BFRI : 1.2400 (+12.73%)
BFRIW : 0.0359 (-10.25%)
Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference

WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0359 (-10.25%)
BFRI : 1.2400 (+12.73%)
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz®

WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0359 (-10.25%)
BFRI : 1.2400 (+12.73%)
Biofrontera Inc. Announces Closing of $9.4 Million Private Placement

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0359 (-10.25%)
BFRI : 1.2400 (+12.73%)
Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022

WOBURN, Mass., May 06, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0359 (-10.25%)
BFRI : 1.2400 (+12.73%)
Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education

Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a...

BFRIW : 0.0359 (-10.25%)
BFRI : 1.2400 (+12.73%)

Business Summary

Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields of photodynamic therapy and topical antibiotics. The Company's licensed products focus on the treatment of actinic keratoses,...

See More

Key Turning Points

3rd Resistance Point 1.4783
2nd Resistance Point 1.3667
1st Resistance Point 1.3033
Last Price 1.2400
1st Support Level 1.1283
2nd Support Level 1.0167
3rd Support Level 0.9533

See More

52-Week High 12.5600
Fibonacci 61.8% 7.9951
Fibonacci 50% 6.5850
Fibonacci 38.2% 5.1749
Last Price 1.2400
52-Week Low 0.6100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar